Molecular targets for COVID-19 drug development: enlightening Nigerians about the pandemic and future treatment Y Muhammed Biosafety and Health 2 (04), 210-216, 2020 | 32 | 2020 |
SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: a review Y Muhammed, AY Nadabo, M Pius, B Sani, J Usman, NA Garba, JM Sani, ... Biosafety and health 3 (05), 249-263, 2021 | 20 | 2021 |
The best IgG subclass for the development of therapeutic monoclonal antibody drugs and their commercial production: a review Y Muhammed Immunome Research 16 (1), 1-12, 2020 | 19 | 2020 |
Scanning ion conductance microscopy revealed cisplatin-induced morphological changes related to apoptosis in single adenocarcinoma cells Y Muhammed, RA Lazenby Analytical Methods 16 (4), 503-514, 2024 | 1 | 2024 |
Breakthroughs in SARS-CoV-2-monoclonal antibodies development Y Muhammed, M Pius, B Sani, B Timothy, J Usman, M Garba Novel Research in Microbiology Journal 5 (1), 1063-1076, 2021 | 1 | 2021 |
Anthrax outbreak in Nigeria: Government initiatives and response to protect livestock and public health J Usman, F Sanusi, Y Muhammed, AH Balarabe, UA Muhammad Microbes and Infectious Diseases 5 (2), 686-687, 2024 | | 2024 |
SARS-CoV-2 Spike Protein and RNA Dependent RNA Polymerase as Targets for Drug and Vaccine Development: State-of-the-art Review Y Muhammed, AY Nadabo, J Usman, NA Garba, J Mohammed, ... | | |